|
PDIA4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.66380251190412E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.44689999995273E-06 |
| Normal-vs-Stage2 |
2.678100E-02 |
| Normal-vs-Stage3 |
2.160800E-03 |
| Normal-vs-Stage4 |
4.094000E-02 |
| Stage1-vs-Stage2 |
4.421200E-01 |
| Stage1-vs-Stage3 |
9.291800E-02 |
| Stage1-vs-Stage4 |
7.680800E-01 |
| Stage2-vs-Stage3 |
5.094200E-01 |
| Stage2-vs-Stage4 |
7.261600E-01 |
| Stage3-vs-Stage4 |
2.470000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6255996548864E-10 |
| Normal-vs-AfricanAmerican |
3.80130000000589E-05 |
| Normal-vs-Asian |
3.114000E-01 |
| Caucasian-vs-AfricanAmerican |
1.181190E-01 |
| Caucasian-vs-Asian |
7.245600E-01 |
| AfricanAmerican-vs-Asian |
5.859600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.10630000002854E-08 |
| Normal-vs-Female |
6.45029996082513E-09 |
| Male-vs-Female |
1.381640E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.406200E-04 |
| Normal-vs-Extreme_Weight |
6.19739999999647E-05 |
| Normal-vs-Obese |
1.56481999999958E-05 |
| Normal-vs-Extreme_Obese |
2.898200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.756800E-01 |
| Normal_Weight-vs-Obese |
8.288200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.296800E-01 |
| Extreme_Weight-vs-Obese |
4.793400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.873800E-01 |
| Obese-vs-Extreme_Obese |
5.399000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.275300E-03 |
| Normal-vs-Age(41-60Yrs) |
6.10109962551064E-10 |
| Normal-vs-Age(61-80Yrs) |
1.41440000001047E-06 |
| Normal-vs-Age(81-100Yrs) |
4.576100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.838200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.758200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.194590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.155590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.603000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.794000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.94369964567898E-10 |
| Normal-VS-Type2 PRCC |
1.482430E-03 |
| Normal-VS-KIRP CIMP |
1.144400E-02 |
| Normal-VS-Unclassified PRCC |
9.158600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.622000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.919760E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.167000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.846580E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.107630E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.571200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.394200E-04 |
| Normal-vs-N1 |
1.584740E-03 |
| Normal-vs-N2 |
1.048630E-01 |
| N0-vs-N1 |
4.888200E-02 |
| N0-vs-N2 |
1.990760E-01 |
| N1-vs-N2 |
5.626400E-01 |
|
|
